Export 1816 results:
Autore Titolo Tipo [ Anno(Desc)]
Filtri: First Letter Of Last Name è M  [Clear All Filters]
2018
Colombo EA, Locatelli A, Sánchez LCubells, Romeo S, Elcioglu NH, Maystadt I, Martínez AEsteve, Sironi A, Fontana L, Finelli P, Gervasini C, Pecile V, Larizza L. Rothmund-Thomson Syndrome: Insights from New Patients on the Genetic Variability Underpinning Clinical Presentation and Cancer Outcome. Int J Mol Sci 2018;19(4)
Colombo EA, Locatelli A, Sánchez LCubells, Romeo S, Elcioglu NH, Maystadt I, Martínez AEsteve, Sironi A, Fontana L, Finelli P, Gervasini C, Pecile V, Larizza L. Rothmund-Thomson Syndrome: Insights from New Patients on the Genetic Variability Underpinning Clinical Presentation and Cancer Outcome. Int J Mol Sci 2018;19(4)
Poropat F, Cozzi G, Magnolato A, Monasta L, Borrometi F, Krauss B, Ventura A, Barbi E. Teaching pain recognition through art: the Ramsay-Caravaggio sedation scale. Ital J Pediatr 2018;44(1):20.
Poropat F, Cozzi G, Magnolato A, Monasta L, Borrometi F, Krauss B, Ventura A, Barbi E. Teaching pain recognition through art: the Ramsay-Caravaggio sedation scale. Ital J Pediatr 2018;44(1):20.
Maximova N, Gregori M, Simeone R, Sonzogni A, Zanon D, Boz G, D'Antiga L. Total body irradiation and iron chelation treatment are associated with pancreatic injury following pediatric hematopoietic stem cell transplantation. Oncotarget 2018;9(28):19543-19554.
Castellano G, Divella C, Sallustio F, Montinaro V, Curci C, Zanichelli A, Bonanni E, Suffritti C, Caccia S, Bossi F, Gallone A, Schena FPaolo, Gesualdo L, Cicardi M. A transcriptomics study of hereditary angioedema attacks. J Allergy Clin Immunol 2018;142(3):883-891.
Maximova N, Sonzogni A, Matarazzo L, Ghirardi A, D'Antiga L. Vanishing Bile Ducts in the Long Term after Pediatric Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2018;24(11):2250-2258.
Maximova N, Sonzogni A, Matarazzo L, Ghirardi A, D'Antiga L. Vanishing Bile Ducts in the Long Term after Pediatric Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2018;24(11):2250-2258.
Fucile C, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, Maximova N. What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis. Ther Clin Risk Manag 2018;14:1649-1655.
Fucile C, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, Maximova N. What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis. Ther Clin Risk Manag 2018;14:1649-1655.
Fucile C, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, Maximova N. What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis. Ther Clin Risk Manag 2018;14:1649-1655.
Fucile C, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, Maximova N. What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis. Ther Clin Risk Manag 2018;14:1649-1655.

Amministrazione Trasparente